US Stock MarketDetailed Quotes

BLRX BioLine Rx

Watchlist

0.540
+0.004+0.73%

Close Oct 1 16:00 ET

0.540
0.0000.00%

Post 18:20 ET

43.17MMarket Cap-1192P/E (TTM)

BioLine Rx Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-17.01%-11.33M

-76.01%-14.11M

13.84%-22.61M

187.98%4.99M

-13.91%-9.9M

-53.95%-9.68M

-43.50%-8.02M

-11.31%-26.24M

-3.09%-5.67M

-73.39%-8.69M

Net income from continuing operations

102.61%484K

94.28%-696K

-142.93%-60.61M

-142.26%-13.88M

-134.01%-16.02M

-149.16%-18.55M

-146.69%-12.16M

7.77%-24.95M

-33.16%-5.73M

-19.79%-6.85M

Operating gains losses

-198.13%-7.92M

-248.39%-4.52M

291.38%11.24M

15.66%-3.03M

425.75%3.15M

6,604.84%8.07M

355.54%3.05M

-429.09%-5.87M

-53.33%-3.59M

-26.08%-967K

Depreciation and amortization

140.40%476K

246.33%897K

111.62%1.38M

277.54%706K

44.44%221K

40.43%198K

49.71%259K

-6.97%654K

7.47%187K

-8.38%153K

Other non cash items

125.33%2.39M

236.09%447K

161.35%1.16M

-200.18%-1.14M

278.62%1.11M

11,900.00%1.06M

304.62%133K

1,041.03%445K

5,533.33%1.14M

-4,684.62%-622K

Change In working capital

-659.92%-7.2M

-4,045.05%-10.77M

1,127.71%15.2M

1,064.37%14.71M

215.30%1.17M

-216.18%-948K

58.72%273K

329.26%1.24M

111.56%1.26M

-197.03%-1.01M

-Change in receivables

---347K

---2.47M

---358K

----

--0

----

-Change in inventory

---745K

---936K

---1.95M

---601K

---1.35M

--0

----

-Change in prepaid assets

47.43%-440K

166.94%81K

-47.54%-959K

-64.44%-393K

41.52%392K

-38.12%-837K

-47.56%-121K

-2,808.33%-650K

-164.25%-239K

-67.94%277K

-Change in payables and accrued expense

-1,811.71%-2.12M

-991.12%-3.51M

191.95%5.51M

106.46%3.1M

264.96%2.13M

-107.81%-111K

55.12%394K

434.75%1.89M

567.56%1.5M

-816.67%-1.29M

-Change in other working capital

---3.55M

---3.93M

--12.96M

----

Cash from discontinued investing activities

Operating cash flow

-17.01%-11.33M

-76.01%-14.11M

13.84%-22.61M

187.82%4.99M

-14.04%-9.9M

-53.95%-9.68M

-43.50%-8.02M

-11.31%-26.24M

-3.27%-5.68M

-73.19%-8.68M

Investing cash flow

Cash flow from continuing investing activities

-177.88%-8.65M

151.23%16.69M

-63.95%1.44M

-628.09%-20.4M

127.43%4.1M

10.66%11.1M

31.58%6.64M

110.48%4.01M

-3.40%3.86M

-37,437.50%-14.94M

Net PPE purchase and sale

59.70%-27K

0.00%-32K

11.45%-116K

71.93%-16K

91.67%-1K

-52.27%-67K

-77.78%-32K

-35.05%-131K

41.24%-57K

-131.58%-12K

Net intangibles purchase and sale

--0

2.16%-181K

98.83%-2K

-85.71%-26K

---56K

---97K

---185K

-588.57%-171K

---14K

Net investment purchase and sale

-176.79%-8.62M

146.92%16.72M

-59.72%1.74M

-598.22%-20.38M

127.66%4.12M

11.39%11.22M

33.66%6.77M

111.34%4.32M

0.74%4.09M

-40,394.59%-14.91M

Cash from discontinued investing activities

Investing cash flow

-177.88%-8.65M

151.23%16.69M

-63.95%1.44M

-628.09%-20.4M

127.43%4.1M

10.66%11.1M

31.58%6.64M

110.48%4.01M

-3.40%3.86M

-37,437.50%-14.94M

Financing cash flow

Cash flow from continuing financing activities

17,920.15%23.88M

-1,724.49%-894K

-26.33%15.06M

1,914.53%11.74M

-84.60%3.5M

80.55%-134K

94.80%-49K

-64.61%20.44M

-471.84%-647K

1,342.35%22.72M

Net issuance payments of debt

13,767.16%18.31M

-1,724.49%-894K

-132.73%-1.99M

-32.77%-863K

-110.92%-942K

86.00%-134K

94.80%-49K

270.04%6.07M

29.73%-650K

1,083.35%8.62M

Net common stock issuance

----

-1.88%14.09M

--12.19M

-86.55%1.9M

----

-71.51%14.36M

--0

474.76%14.09M

Proceeds from stock option exercised by employees

----

59,000.00%2.96M

13,566.67%410K

----

-99.95%5K

--3K

--0

Cash from discontinued financing activities

Financing cash flow

17,920.15%23.88M

-1,724.49%-894K

-26.33%15.06M

1,914.53%11.74M

-84.60%3.5M

80.55%-134K

94.80%-49K

-64.61%20.44M

-471.84%-647K

1,342.35%22.72M

Net cash flow

Beginning cash position

-33.93%5.99M

-59.81%4.26M

-18.50%10.59M

-41.04%7.73M

-27.83%10.1M

-20.79%9.07M

-18.50%10.59M

-22.82%12.99M

-6.90%13.11M

-19.93%14M

Current changes in cash

204.13%3.91M

218.34%1.68M

-240.09%-6.11M

-48.46%-3.66M

-156.11%-2.31M

-57.94%1.28M

3.92%-1.42M

55.63%-1.8M

-85.42%-2.47M

73.51%-900K

Effect of exchange rate changes

-10.57%-272K

152.04%51K

63.10%-224K

484.00%192K

-1,540.00%-72K

50.70%-246K

-55.56%-98K

-393.24%-607K

-120.49%-50K

155.56%5K

End cash Position

-4.76%9.62M

-33.93%5.99M

-59.81%4.26M

-41.04%7.73M

-27.83%10.1M

-20.79%9.07M

-18.50%10.59M

-6.90%13.11M

Free cash flow

-15.82%-11.36M

-73.62%-14.14M

13.75%-22.91M

184.13%4.97M

-14.01%-9.93M

-54.82%-9.81M

-45.34%-8.15M

-12.19%-26.56M

-6.22%-5.91M

-73.81%-8.71M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-17.01%-11.33M	-76.01%-14.11M	13.84%-22.61M	187.98%4.99M	-13.91%-9.9M	-53.95%-9.68M	-43.50%-8.02M	-11.31%-26.24M	-3.09%-5.67M	-73.39%-8.69M
Net income from continuing operations	102.61%484K	94.28%-696K	-142.93%-60.61M	-142.26%-13.88M	-134.01%-16.02M	-149.16%-18.55M	-146.69%-12.16M	7.77%-24.95M	-33.16%-5.73M	-19.79%-6.85M
Operating gains losses	-198.13%-7.92M	-248.39%-4.52M	291.38%11.24M	15.66%-3.03M	425.75%3.15M	6,604.84%8.07M	355.54%3.05M	-429.09%-5.87M	-53.33%-3.59M	-26.08%-967K
Depreciation and amortization	140.40%476K	246.33%897K	111.62%1.38M	277.54%706K	44.44%221K	40.43%198K	49.71%259K	-6.97%654K	7.47%187K	-8.38%153K
Other non cash items	125.33%2.39M	236.09%447K	161.35%1.16M	-200.18%-1.14M	278.62%1.11M	11,900.00%1.06M	304.62%133K	1,041.03%445K	5,533.33%1.14M	-4,684.62%-622K
Change In working capital	-659.92%-7.2M	-4,045.05%-10.77M	1,127.71%15.2M	1,064.37%14.71M	215.30%1.17M	-216.18%-948K	58.72%273K	329.26%1.24M	111.56%1.26M	-197.03%-1.01M
-Change in receivables	---347K	---2.47M	---358K	----	----	--0	--0	--0	----	----
-Change in inventory	---745K	---936K	---1.95M	---601K	---1.35M	--0	--0	--0	--0	----
-Change in prepaid assets	47.43%-440K	166.94%81K	-47.54%-959K	-64.44%-393K	41.52%392K	-38.12%-837K	-47.56%-121K	-2,808.33%-650K	-164.25%-239K	-67.94%277K
-Change in payables and accrued expense	-1,811.71%-2.12M	-991.12%-3.51M	191.95%5.51M	106.46%3.1M	264.96%2.13M	-107.81%-111K	55.12%394K	434.75%1.89M	567.56%1.5M	-816.67%-1.29M
-Change in other working capital	---3.55M	---3.93M	--12.96M	----	----	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	-17.01%-11.33M	-76.01%-14.11M	13.84%-22.61M	187.82%4.99M	-14.04%-9.9M	-53.95%-9.68M	-43.50%-8.02M	-11.31%-26.24M	-3.27%-5.68M	-73.19%-8.68M
Investing cash flow
Cash flow from continuing investing activities	-177.88%-8.65M	151.23%16.69M	-63.95%1.44M	-628.09%-20.4M	127.43%4.1M	10.66%11.1M	31.58%6.64M	110.48%4.01M	-3.40%3.86M	-37,437.50%-14.94M
Net PPE purchase and sale	59.70%-27K	0.00%-32K	11.45%-116K	71.93%-16K	91.67%-1K	-52.27%-67K	-77.78%-32K	-35.05%-131K	41.24%-57K	-131.58%-12K
Net intangibles purchase and sale	--0	--0	2.16%-181K	98.83%-2K	-85.71%-26K	---56K	---97K	---185K	-588.57%-171K	---14K
Net investment purchase and sale	-176.79%-8.62M	146.92%16.72M	-59.72%1.74M	-598.22%-20.38M	127.66%4.12M	11.39%11.22M	33.66%6.77M	111.34%4.32M	0.74%4.09M	-40,394.59%-14.91M
Cash from discontinued investing activities
Investing cash flow	-177.88%-8.65M	151.23%16.69M	-63.95%1.44M	-628.09%-20.4M	127.43%4.1M	10.66%11.1M	31.58%6.64M	110.48%4.01M	-3.40%3.86M	-37,437.50%-14.94M
Financing cash flow
Cash flow from continuing financing activities	17,920.15%23.88M	-1,724.49%-894K	-26.33%15.06M	1,914.53%11.74M	-84.60%3.5M	80.55%-134K	94.80%-49K	-64.61%20.44M	-471.84%-647K	1,342.35%22.72M
Net issuance payments of debt	13,767.16%18.31M	-1,724.49%-894K	-132.73%-1.99M	-32.77%-863K	-110.92%-942K	86.00%-134K	94.80%-49K	270.04%6.07M	29.73%-650K	1,083.35%8.62M
Net common stock issuance	----	----	-1.88%14.09M	--12.19M	-86.55%1.9M	----	----	-71.51%14.36M	--0	474.76%14.09M
Proceeds from stock option exercised by employees	----	----	59,000.00%2.96M	13,566.67%410K	----	----	----	-99.95%5K	--3K	--0
Cash from discontinued financing activities
Financing cash flow	17,920.15%23.88M	-1,724.49%-894K	-26.33%15.06M	1,914.53%11.74M	-84.60%3.5M	80.55%-134K	94.80%-49K	-64.61%20.44M	-471.84%-647K	1,342.35%22.72M
Net cash flow
Beginning cash position	-33.93%5.99M	-59.81%4.26M	-18.50%10.59M	-41.04%7.73M	-27.83%10.1M	-20.79%9.07M	-18.50%10.59M	-22.82%12.99M	-6.90%13.11M	-19.93%14M
Current changes in cash	204.13%3.91M	218.34%1.68M	-240.09%-6.11M	-48.46%-3.66M	-156.11%-2.31M	-57.94%1.28M	3.92%-1.42M	55.63%-1.8M	-85.42%-2.47M	73.51%-900K
Effect of exchange rate changes	-10.57%-272K	152.04%51K	63.10%-224K	484.00%192K	-1,540.00%-72K	50.70%-246K	-55.56%-98K	-393.24%-607K	-120.49%-50K	155.56%5K
End cash Position	-4.76%9.62M	-33.93%5.99M	-59.81%4.26M	-59.81%4.26M	-41.04%7.73M	-27.83%10.1M	-20.79%9.07M	-18.50%10.59M	-18.50%10.59M	-6.90%13.11M
Free cash flow	-15.82%-11.36M	-73.62%-14.14M	13.75%-22.91M	184.13%4.97M	-14.01%-9.93M	-54.82%-9.81M	-45.34%-8.15M	-12.19%-26.56M	-6.22%-5.91M	-73.81%-8.71M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data